We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Comparison of Ketamine and Esketamine in Patients Suffering From Fibromyalgia Syndrome. (KESK-FIQ)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04938713
Recruitment Status : Recruiting
First Posted : June 24, 2021
Last Update Posted : August 27, 2021
Centre Hospitalier Universitaire de Liege
Information provided by (Responsible Party):
Brice Constant, MD, Centre Hospitalier Universitaire de Charleroi

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 1, 2022
Estimated Study Completion Date : September 30, 2022